CompletedN/Aketamine

Neuromodulation to Facilitate the Effect of Ketamine

Sponsored by The Neuroscience Center, LLC

NCT ID
NCT01816958
Target Enrollment
35 participants
Start Date
2011-01
Est. Completion
2012-11

About This Study

application of external neuromodulation along with ketamine infusion.

Conditions Studied

DepressionChronic PainSubstance Abuse

Interventions

  • co-administration of TMS and infused ketamine

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* chronically ill,
* treatment-resistant

Exclusion Criteria:

* active psychosis

Study Locations (1)

The Neuroscience Center
Deerfield, Illinois, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source